The age-adjusted Charlson comorbidity index is a better predictor of survival in operated lung cancer patients than the Charlson and Elixhauser comorbidity indices - Yang, C-C; Fong, Y; Lin, L-C (Eur J Cardiothorac Surg, 2018)
, et al.